251
|
|
|
Mitochondrial calcium uniporter dominant negative subunit beta |
CCDC109B |
|
252
|
|
|
Mitochondrial calcium uniporter regulator 1 |
C6orf79, CCDC90A, FMP32 |
|
253
|
|
|
MyoD family inhibitor |
I-MF, I-mfa |
|
254
|
|
|
MyoD family inhibitor domain containing |
HIC, LMPHM12, MDFIC1 |
Alzheimer disease, Bilirubin metabolism disease, Bipolar disorder, Breast cancer, Crohn disease, Hoarding disorder, Inflammatory bowel disease, Insomnia, Lymphatic malformation, Major depressive disorder, Metabolic syndrome, Obesity, Oligodendroglioma, Osteoarthritis, Pelvic organ prolapse, Schizophrenia, Diabetes mellitus type 2View all (2 more) |
255
|
|
|
MyoD family inhibitor domain containing 2 |
- |
|
256
|
|
|
MAM domain containing glycosylphosphatidylinositol anchor 1 |
GPIM, MAMDC3 |
|
257
|
|
|
MAM domain containing glycosylphosphatidylinositol anchor 2 |
MAMDC1, c14_5286 |
Anorexia nervosa, Attention deficit hyperactivity disorder, Bronchopulmonary dysplasia, Central nervous system cancer, Color vision deficiency, Gestational diabetes, Glioma, Idiopathic pulmonary fibrosis, Insomnia, Intellectual developmental disorder, Lung cancer, Major depressive disorder, Renal pelvis neoplasms, Metabolic syndrome, Multiple system atrophy, Neurotic disorder, Obesity, Ocular sarcoidosis, Parkinson disease, Post-traumatic stress disorder, Schizophrenia, Substance abuse, Diabetes mellitus type 2View all (8 more) |
258
|
|
|
Malate dehydrogenase 1 |
DEE88, EIEE88, HEL-S-32, KAR, MDH-s, MDHA, MGC:1375, MOR2 |
|
259
|
|
|
Malate dehydrogenase 2 |
DEE51, EIEE51, M-MDH, MDH, MGC:3559, MOR1 |
|
260
|
|
|
Midkine |
ARAP, MK, NEGF2 |
|
